TGen - Part of City of Hope
Biotechnology ResearchArizona, United States201-500 Employees
TGen, the Translational Genomics Research Institute and a component of City of Hope, operates as a mid-sized nonprofit organization focused on turning genomic insights into earlier diagnostic options and more effective therapies. Located in Phoenix, Arizona, the institute builds on advances from the Human Genome Project to develop diagnostics and treatments for cancer, neurological disorders, rare childhood diseases, infectious diseases, and other complex conditions. In the biotechnology research landscape, it serves as a conduit between laboratory findings and clinical practice, aiming to accelerate the translation of discoveries into patient care. In May 2026, TGen announced the launch of JAYseq, a clinical whole-genome sequencing test designed for multiple myeloma. The development underscores its focus on precision oncology and applying genomics to customized patient care.